Masakazu Fujio

Masakazu Fujio is a seasoned professional in medicinal chemistry and business development with extensive experience in the pharmaceutical industry. Currently serving as Senior Manager for New Business Planning & Control at Teijin Limited since January 2023, Fujio previously held significant roles at TAISHO PHARMACEUTICAL CO., LTD., where responsibilities included Group Manager and Manager in Licensing and Business Development, focusing on the in-licensing of clinical stage assets. Prior to this, Fujio worked at Mitsubishi Tanabe Pharma Corporation for over two decades, contributing as a Medicinal Chemist and Project Manager, notably on CNS and cardiovascular projects, including the successful identification of MP-124 as a clinical candidate. Fujio holds a Ph.D. in Medicinal and Pharmaceutical Chemistry from Kyushu University and further pursued research at the Scripps Research Institute.